Physician

Hayden N Hemphill, MD

According to 2025 Medicare claims, Hayden Hemphill, MD (NPI: 1396746376) practices nephrology in the Texarkana, TX-AR market, with the plurality of this provider's patient population coming from Bowie, TX. This provider's primary affiliated billing organization is COLLOM & CARNEY CLINIC ASSOCIATION (NPI: 1265414635; TIN: 751151440) and primary practice location at 75503-9766. Hemphill is affiliated with the Prime Care Managers, LLC (ACO ID: A3280), participating under the MSSP model.

Hemphill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 550 traditional Medicare patients, billed 5,015 HCPCS/CPT codes, and received $248,614 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,526 prescription claims across 274 beneficiaries totaling $134,966 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 137 claims. Open Payments data shows 36 records totaling $773. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $301,398 to $248,614. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $586,954 to $134,966. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,429 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$236K$473K2015 Medicare payment: $301,398 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $358,687 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $472,964 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $411,795 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $362,722 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $336,613 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $323,109 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $255,792 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $258,032 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $248,614 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155625,467$301,398
20166619,700$358,687
20177209,434$472,964
20187038,214$411,795
20196906,472$362,722
20206616,808$336,613
20215706,563$323,109
20225635,432$255,792
20235555,396$258,032
20245505,015$248,614

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$337K$674K2015 Drug cost: $586,954 (USD; Tot_Drug_Cst)2016 Drug cost: $567,889 (USD; Tot_Drug_Cst)2017 Drug cost: $673,659 (USD; Tot_Drug_Cst)2018 Drug cost: $450,297 (USD; Tot_Drug_Cst)2019 Drug cost: $359,310 (USD; Tot_Drug_Cst)2020 Drug cost: $325,032 (USD; Tot_Drug_Cst)2021 Drug cost: $229,606 (USD; Tot_Drug_Cst)2022 Drug cost: $238,093 (USD; Tot_Drug_Cst)2023 Drug cost: $242,517 (USD; Tot_Drug_Cst)2024 Drug cost: $134,966 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151933,447$586,954
20162492,835$567,889
20173063,421$673,659
20183153,304$450,297
20193072,948$359,310
20202902,431$325,032
20212781,943$229,606
20222571,718$238,093
20232621,533$242,517
20242741,526$134,966

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$33K2015 Medicare payment: $16,454 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $14,351 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $24,748 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $31,061 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $32,837 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $18,539 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $8,532 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $9,935 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,050 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,854 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R221$16,454
2016N/R190$14,351
201711348$24,748
201812408$31,061
2019N/R358$32,837
2020N/R244$18,539
2021N/R214$8,532
2022N/R297$9,935
2023N/R182$5,050
2024N/R137$2,854

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more178292$85
36415Insertion of needle into vein for collection of blood sample179300$9
82570Creatinine level to test for kidney function or muscle injury185295$5
84156Total protein level, urine183293$4
81001Manual urinalysis test with examination using microscope, automated187306$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FarxigaDapagliflozin Propanediol371,530$25,892
Sevelamer CarbonateSevelamer Carbonate612,622$17,027
EliquisApixaban23750$14,716
RenvelaSevelamer Carbonate15459$13,870
VelphoroSucroferric Oxyhydroxide11150$11,229

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7518Mycophenolic acid, oral, 180 mgNN/R20$775
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R39$734
J7507Tacrolimus, immediate release, oral, 1 mgNN/R29$718
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R49$627

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$773Ardelyx, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Hayden N. Hemphill, MD?

Tedicare shows public-source Medicare data for Hayden N. Hemphill, MD (NPI 1396746376), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hayden N. Hemphill, MD have ACO affiliation data?

Hayden N. Hemphill, MD is shown with ACO affiliation data for Prime Care Managers, LLC (MSSP, ACO ID A3280).

What billing organization is linked to Hayden N. Hemphill, MD?

Hayden N. Hemphill, MD is linked to COLLOM & CARNEY CLINIC ASSOCIATION (billing NPI 1265414635) in the available physician profile data.

Does Hayden N. Hemphill, MD have Open Payments data?

Hayden N. Hemphill, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.